1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 636 F.Supp.3d
  5. 636 F.Supp.3d 539 (2022)
 

IN RE SUBOXONE

MDL NO. 2445 13-MD-2445 CIV. A. NO. 16-5073.

636 F.Supp.3d 539 (2022)

IN RE SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE) ANTITRUST LITIGATION This Document Relates to: Wisconsin, et al. v. Indivior Inc. et al. State of Wisconsin, by Attorney General Brad D. Schimel, et al., Plaintiffs, v. Indivior Inc. f/k/a Reckitt Benckiser Pharmaceuticals, Inc., et al., Defendants.

United States District Court, E.D. Pennsylvania.

Filed October 19, 2022.

MEMORANDUM OPINION

This multidistrict litigation case involves an alleged "product hop" antitrust scheme wherein the patent holder allegedly sought to maintain market exclusivity by changing the formulation of its product.

Defendant...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases